Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Join Dr. Stephen Krieger (@SKriegerMD), a Professor Neurology at the Corinne Goldsmith Dickinson Center for MS at Mount Sinai, in a unique CE/CME-accredited video. Dr. Krieger sits down for an honest 1:1 conversation with one of his first patients, Kate Milliken, with whom he has had a doctor-patient relationship for 15 years. They discuss how considering the patient’s perspective is ...
View Course
Applying JAK Inhibitor Therapeutics to Improve Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis

Program Overview

This CME/CE program is derived from content presented at the Maui Derm for Dermatologists 2022 Annual Meeting. The expert faculty, led by Lawrence Eichenfield, MD, will highlight the use of Janus kinases (JAK) inhibitor therapeutics to improve outcomes in patients with atopic dermatitis. The faculty will begin with an overview of current clinical trial data, including new and ...
View Course

Advances in the Management of Patients with Metastatic Breast Cancer

Program Overview

This CME/CE program will outline recent advances in the treatment and management of patients with metastatic breast cancer. The expert faculty, led by Dr. Harold J. Burstein, will first cover ER-positive breast cancer, analyzing data for CDK 4/6 inhibitors, ER targeting agents and antibody drug conjugates. Following, pertinent information regarding triple negative breast cancer will be reviewed, highlighting ...
View Course
Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies

Program Overview

This CME/CE program will highlight recent advances in disease management of generalized myasthenia gravis (MG) by reducing levels of IgG autoantibodies. The expert faculty, led by Dr. James F. Howard, will first cover the pathophysiology of MG, including therapeutic approaches and general limitations for current immunosuppressant therapies. Following, current clinical trial data of FcRn Inhibitors in myasthenia gravis ...
View Course
Updates in Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack

Program Overview

This CME/CE program highlights recent advances in the treatment and management of patients with ischemic stroke and transient ischemic attack (TIA). The expert faculty, led by Dr. Stephan Mayer, will first outline pathophysiology of thrombosis, platelet vessel interactions, and recurrent stroke, including discussion of oral antiplatelet agents. The faculty will also review best practices for secondary prevention of ...
View Course
Optimal Strategies for the Management of Venous Thromboembolism

Program Overview

This CME/CE program provides a comprehensive overview of the diagnosis, risk stratification, and management strategies of acute deep vein thrombosis (DVT) and pulmonary embolism (PE).  There is an emphasis on care in the outpatient setting, and on new therapeutics that may shorten or even obviate the need for hospitalization. The expert faculty discuss clinical data on current therapeutic ...
View Course

Upcoming Events

Eastern Pulmonary Conference 2022

September 8th – 11th, 2022

Congress of Clinical Rheumatology West Meeting

October 20th – 23rd, 2022

ASHP Midyear Clinical Meeting and Exhibition

December 4th – 8th, 2022

The Alliance 2023 Annual Conference

January 11th – 14th, 2023